Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 O-I Glass, Inc. OI Aug 4, 2021 14.73 -4.10   
 O2Micro International Limited - American Depositary Shares OIIM Aug 4, 2021 7.25 -0.96   
 Oak Street Health Inc OSH Aug 4, 2021 64.25 +0.53   
 Oak Valley Bancorp (CA) OVLY Aug 4, 2021 17.45 -0.65   
 Oaktree Acquisition Corp II OACB Aug 4, 2021 9.85 +0.31   
 Oaktree Capital Group LLC 6.55% PRF PERPETUAL USD 25 - Ser B OAK-B Aug 4, 2021 28.02 -0.01   
 Oaktree Capital Group LLC 6.625% PRF PERPETUAL USD 25 - Ser OAK-A Aug 4, 2021 27.72 -0.04   
 Oaktree Specialty Lending Corporation OCSL Aug 4, 2021 6.85 +0.29   
 Oasis Midstream Partners LP - Common Units, Representing Lim OMP Aug 4, 2021 22.30 +0.91   
 Oasis Petroleum Inc. OAS Aug 4, 2021 87.08 -1.60   
 Oatly Group AB - American Depositary Shares OTLY Aug 4, 2021 18.04 0.00   
 Oblong Inc. OBLG Aug 4, 2021 2.61 +1.56   
 ObsEva SA - OBSV Aug 4, 2021 2.49 -0.40   
 OCA Acquisition Corp. - Class A OCAX Aug 4, 2021 9.82 +0.20   
 OCA Acquisition Corp. - Unit OCAXU Aug 4, 2021 10.08 -0.24   
 Occidental Petroleum Corporation OXY Aug 4, 2021 25.69 -2.80   
 Ocean Bio-Chem, Inc. OBCI Aug 4, 2021 11.47 +0.61   
 Ocean Power Technologies, Inc. OPTT Aug 4, 2021 1.89 -0.53   
 Oceaneering International, Inc. OII Aug 4, 2021 11.95 -10.42   
 OceanFirst Financial Corp. OCFC Aug 4, 2021 20.00 +2.20   
 OceanFirst Financial Corp. - Depositary Shares OCFCP Aug 4, 2021 28.00 -0.89   
 OceanTech Acquisitions I Corp. - Units OTECU Aug 4, 2021 10.30 0.00   
 Oconee Federal Financial Corp. OFED Aug 4, 2021 21.88 -0.55   
 Ocugen, Inc. OCGN Aug 4, 2021 6.79 -3.69   
 Ocular Therapeutix, Inc. OCUL Aug 4, 2021 10.51 -2.50   
 Ocuphire Pharma, Inc. OCUP Aug 4, 2021 4.41 -5.57   
 Ocwen Financial Corporation NEW OCN Aug 4, 2021 25.93 -4.00   
 Odonate Therapeutics, Inc. ODT Aug 4, 2021 3.30 +4.10   
 Odyssey Marine Exploration, Inc. OMEX Aug 4, 2021 5.55 -1.42   
 Office Properties Income Trust - OPI Aug 4, 2021 27.19 -3.31   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK